Literature DB >> 30465220

Prognostic Factors and Appropriate Lymph Node Dissection in Salvage Esophagectomy for Locally Advanced T4 Esophageal Cancer.

Yu Ohkura1,2, Masaki Ueno3,4, Toshiro Iizuka4,5, Harushi Udagawa3,4.   

Abstract

BACKGROUND: A suitable treatment strategy for esophageal cancer after definitive chemoradiotherapy for T4 cases has not been established and remains unclear. This study aimed to clarify the independent prognostic factors, surgical indications, and optimal extent of lymphadenectomy for T4 esophageal cancer.
METHODS: Of 803 patients who underwent esophagectomy for esophageal cancer at the authors' institution from 2006 to March 2018, the study included 33 patients who underwent salvage esophagectomy with locally advanced T4 cancer. The study examined the baseline attributes and treatment results of these cases and evaluated the prognostic factors and treatment strategies.
RESULTS: The independent favorable prognostic factors in T4 cancer (T4a/T4b = 11/22) included non-T4b status [hazard ratio (HR), 15.311; 95% confidence-interval (CI), 1.277-183.5] and R0 resection (HR, 14.706; 95% CI, 1.193-166.67). For the cases in which R0 resection was possible (n = 14), both the 1- and 5-year survival rates were 90.9%, whereas for the cases without R0 dissection (n = 19), the 1- and 5-year survival rates were respectively 44.9% and 0%. In the univariate analysis, the patients who underwent two- or three-field lymph node dissection tended to have a better prognosis (p = 0.062), and those with 60 or more lymph nodes dissected had a significantly better prognosis (p = 0.038). For the patients who underwent salvage esophagectomy with typical lymph node dissection, the rate of complications classified as Clavien-Dindo grade 3 or higher (33.3%) was not increased, indicating that the procedure was relatively safe.
CONCLUSIONS: The results showed that in salvage esophagectomy for T4 esophageal cancer, R0 resection led to improved prognosis. Because typical two- or three-field lymph node dissection including prophylactic dissection could be performed safely and led to a better prognosis in salvage esophagectomy, typical esophagectomy including prophylactic lymph node dissection should be performed if possible.

Entities:  

Mesh:

Year:  2018        PMID: 30465220     DOI: 10.1245/s10434-018-7074-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma.

Authors:  Akihiko Okamura; Masaru Hayami; Ryotaro Kozuki; Keita Takahashi; Tasuku Toihata; Yu Imamura; Shinji Mine; Masayuki Watanabe
Journal:  Esophagus       Date:  2019-10-08       Impact factor: 4.230

Review 2.  Surgical strategies for treatment of clinical T4 esophageal cancer in Japan.

Authors:  Kazuhiko Yamada; Kyoko Nohara; Naoki Enomoto; Hitomi Wake; Syusuke Yagi; Masayoshi Terayama; Daiki Kato; Chizu Yokoi; Yasushi Kojima; Hidetsugu Nakayama; Norihiro Kokudo
Journal:  Glob Health Med       Date:  2021-12-31

3.  Serine 727 phosphorylation is necessary to induce the STAT3-mediated transcription of LINC00184 in oesophageal squamous cell carcinoma.

Authors:  Chengling Jin; Hong Qi; Yue Xu; Shenglei Li
Journal:  Mol Cell Biochem       Date:  2022-03-21       Impact factor: 3.396

4.  Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.

Authors:  Kotaro Sugawara; Koichi Yagi; Yasuhiro Okumura; Masato Nishida; Susumu Aikou; Hiroharu Yamashita; Hideomi Yamashita; Yasuyuki Seto
Journal:  Int J Clin Oncol       Date:  2019-12-11       Impact factor: 3.402

5.  Advantageous factors of R0 curative conversion esophagectomy and the optimal extent of lymphadenectomy after induction therapy for cT4b thoracic esophageal cancer.

Authors:  Yu Ohkura; Masaki Ueno; Harushi Udagawa
Journal:  Ann Gastroenterol Surg       Date:  2020-12-11

6.  Long-term survival after esophagectomy with distal pancreatectomy for locally advanced esophageal cancer with pancreatic invasion: a case report.

Authors:  Yoshiki Kaneko; Katsuji Hisakura; Koichi Ogawa; Yoshimasa Akashi; Yusuke Ohara; Yohei Owada; Tsuyoshi Enomoto; Kinji Furuya; Shoko Moue; Manami Doi; Kazuhiro Takahashi; Osamu Shimomura; Shinji Hashimoto; Noriaki Sakamoto; Tsunehiko Maruyama; Tatsuya Oda
Journal:  Surg Case Rep       Date:  2021-12-14

7.  A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy.

Authors:  Tian Zhang; Zhoubo Guo; Xi Chen; Jie Dong; Hongjing Jiang; Peng Tang; Ping Wang; Dong Qian; Wencheng Zhang; Qingsong Pang
Journal:  Radiat Oncol       Date:  2022-08-23       Impact factor: 4.309

Review 8.  Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma.

Authors:  Koichi Yagi; Tetsuro Toriumi; Susumu Aikou; Hiroharu Yamashita; Yasuyuki Seto
Journal:  Ann Gastroenterol Surg       Date:  2021-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.